Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain

Launched by UNIVERSITY OF CONNECTICUT · Apr 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to measure abdominal pain, especially in people with Irritable Bowel Syndrome (IBS). The researchers want to see how well a special index called the Objective Integrated Multimodal Electrophysiological Index (OIME) can help track pain levels and how effective treatments are for IBS patients. They will collect data from healthy individuals and those with IBS by recording various body signals when they feel pain.

To join this study, participants must be between 18 and 50 years old, have a confirmed diagnosis of IBS, and experience abdominal pain. They should also be comfortable using a computer and have access to the internet. Unfortunately, those with certain other health conditions, such as diabetes or serious mental health issues, or those who are pregnant, cannot participate. This study is not yet recruiting participants, but it aims to help improve pain management for IBS in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants need to be diagnosed with IBS by a healthcare provider according to Rome-III or -IV criteria, with a current report of abdominal pain.
• • Men and women 18-50 years old
• • Able to read and speak English
• • Daily access to a computer with internet access.
• Exclusion Criteria:
• • Other chronic pains that are usually not comorbid with IBS, e.g., diabetic neuropathy, myofascial pain, low back pain, peripheral neuropathy etc.
• • Celiac disease or inflammatory bowel disease
• • Diabetes mellitus; d) Serious mental health conditions
• • Women during pregnancy or within 3 months post-partum period
• • Self- reported Regular use of opioids or other illicit substances.
• • Participants who have had COVID-19 should be fully recovered, and will be asked if their medical provider has made any restriction on activities.